{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T23:51:37Z","timestamp":1784245897889,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81173034"],"award-info":[{"award-number":["81173034"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81072646"],"award-info":[{"award-number":["81072646"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science & Technology Major Project \u201cKey New Drug Creation and Manufacturing Program\u201d of China","award":["2012ZX09301001-004"],"award-info":[{"award-number":["2012ZX09301001-004"]}]},{"name":"Ministry of Science and Technology of China","award":["2011CB510004"],"award-info":[{"award-number":["2011CB510004"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.neuropharm.2015.02.020","type":"journal-article","created":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T04:50:15Z","timestamp":1425358215000},"page":"29-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"C","title":["Donepezil attenuates A\u03b2-associated mitochondrial dysfunction and\u00a0reduces mitochondrial A\u03b2 accumulation in\u00a0vivo and in\u00a0vitro"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8388-2277","authenticated-orcid":false,"given":"Chun Yan","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi Can","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2015.02.020_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1254\/jphs.93.95","article-title":"Pharmacological characterization of RS-1259, an orally active dual inhibitor of acetylcholinesterase and serotonin transporter, in rodents: possible treatment of Alzheimer's disease","volume":"93","author":"Abe","year":"2003","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2014.02.001","article-title":"2014 Alzheimer's disease facts and figures","volume":"10","author":"Alzheimer's Association","year":"2014","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.neuropharm.2015.02.020_bib3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","article-title":"The toxic A\u03b2 oligomer and Alzheimer's disease: an emperor in need of clothes","volume":"15","author":"Benilova","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib4","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1080\/15216540601047767","article-title":"Mitochondrial abeta: a potential cause of metabolic dysfunction in Alzheimer's disease","volume":"58","author":"Chen","year":"2006","journal-title":"IUBMB Life"},{"key":"10.1016\/j.neuropharm.2015.02.020_bib5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.physbeh.2014.04.021","article-title":"Inhalation of coriander volatile oil increased anxiolytic-antidepressant-like behaviors and decreased oxidative status in \u03b2-amyloid (1-42) rat model of Alzheimer's disease","volume":"131","author":"Cioanca","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0165-0270(95)00154-9","article-title":"T-maze and food reinforcement: an inexpensive drug discrimination procedure","volume":"67","author":"Colombo","year":"1996","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2015.02.020_bib7","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2015.02.020_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nprot.2006.2","article-title":"T-maze alternation in the rodent","volume":"1","author":"Deacon","year":"2006","journal-title":"Nat. Protoc."},{"issue":"Suppl.\u00a02","key":"10.1016\/j.neuropharm.2015.02.020_bib9","doi-asserted-by":"crossref","first-page":"S535","DOI":"10.3233\/JAD-2010-100342","article-title":"Mitochondrial amyloid-\u03b2 levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice","volume":"20","author":"Dragicevic","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3233\/JAD-2011-101629","article-title":"Green tea epigallocatechin-3-gallate (EGCG) and other flavonoids reduce Alzheimer's amyloid-induced mitochondrial dysfunction","volume":"26","author":"Dragicevic","year":"2011","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib11","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/nm.1868","article-title":"Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease","volume":"14","author":"Du","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib12","doi-asserted-by":"crossref","first-page":"18670","DOI":"10.1073\/pnas.1006586107","article-title":"Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model","volume":"107","author":"Du","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev-med-092611-084441","article-title":"Toward the treatment and prevention of Alzheimer's disease: rational strategies and recent progress","volume":"64","author":"Gandy","year":"2013","journal-title":"Annu Rev. Med."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib14","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/jnr.20791","article-title":"Huperzine A attenuates mitochondrial dysfunction in \u03b2-amyloid-treated PC12 cells by reducing oxygen free radicals accumulation and improving mitochondrial energy metabolism","volume":"83","author":"Gao","year":"2006","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrneurol.2013.223","article-title":"Alzheimer disease therapy\u2013moving from amyloid-\u03b2 to tau","volume":"9","author":"Giacobini","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib16","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1124\/dmd.110.035964","article-title":"Pharmacokinetic and pharmacodynamic properties of cholinesterase inhibitors donepezil, tacrine, and galantamine in aged and young lister hooded rats","volume":"39","author":"Goh","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/alzrt272","article-title":"Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer's disease immunotherapeutics","volume":"6","author":"Goure","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bbr.2014.06.056","article-title":"Acute systemic rapamycin induces neurobehavioral alterations in rats","volume":"273","author":"Hadamitzky","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib19","doi-asserted-by":"crossref","first-page":"13145","DOI":"10.1073\/pnas.0806192105","article-title":"The amyloid \u03b2-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae","volume":"105","author":"Hansson Petersen","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib20","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1176\/appi.ajp.162.4.676","article-title":"Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?","volume":"162","author":"Hashimoto","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.02.020_bib21","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.neurobiolaging.2007.11.001","article-title":"Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease","volume":"30","author":"He","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2015.02.020_bib22","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.neurobiolaging.2013.11.002","article-title":"Permeability transition pore-mediated mitochondrial superoxide flashes mediate an early inhibitory effect of A\u03b21-42 on neural progenitor cell proliferation","volume":"35","author":"Hou","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2015.02.020_bib23","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1097\/00001756-200210280-00032","article-title":"Amyloid \u03b2 peptide induces cytochrome C release from isolated mitochondria","volume":"13","author":"Kim","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2015.02.020_bib24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrn2168","article-title":"Intracellular amyloid-\u03b2 in Alzheimer's disease","volume":"8","author":"LaFerla","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib25","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","article-title":"Diffusible, nonfibrillar ligands derived from A\u03b2 are potent central nervous system neurotoxins","volume":"95","author":"Lambert","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuropharm.2015.02.020_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1601-183X.2007.00374.x","article-title":"One-year longitudinal evaluation of sensorimotor functions in APP751SL transgenic mice","volume":"7","author":"Le Cudennec","year":"2008","journal-title":"Genes. Brain Behav."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jns.2013.09.018","article-title":"Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP\/PS1 mouse model of Alzheimer's disease","volume":"335","author":"Lok","year":"2013","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib28","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/hmg\/ddl066","article-title":"Mitochondria are a direct site of A\u03b2 accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression","volume":"15","author":"Manczak","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib29","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1474-4422(10)70119-8","article-title":"Alzheimer's disease: clinical trials and drug development","volume":"9","author":"Mangialasche","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neuropharm.2014.07.015","article-title":"Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease","volume":"86","author":"McClean","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.02.020_bib31","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1212\/WNL.46.1.130","article-title":"The spectrum of behavioral changes in Alzheimer's disease","volume":"46","author":"Mega","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2015.02.020_bib32","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/sj.bjp.0706927","article-title":"The anti-amnesic and neuroprotective effects of donepezil against amyloid \u03b225-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor","volume":"149","author":"Meunier","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib33","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1021\/bi401606f","article-title":"Rare individual amyloid-\u03b2 oligomers act on astrocytes to initiate neuronal damage","volume":"53","author":"Narayan","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2015.02.020_bib34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s13318-012-0081-1","article-title":"Concurrent administration of atypical antipsychotics and donepezil: drug interaction study in rats","volume":"37","author":"Nirogi","year":"2012","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib35","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1017\/S1461145710000222","article-title":"Galantamine ameliorates the impairment of recognition memory in mice repeatedly treated with methamphetamine: involvement of allosteric potentiation of nicotinic acetylcholine receptors and dopaminergic-ERK1\/2 systems","volume":"13","author":"Noda","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib36","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1471-4159.2008.05837.x","article-title":"Neuroprotective effects of donepezil through inhibition of GSK-3 activity in amyloid-\u03b2-induced neuronal cell death","volume":"108","author":"Noh","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000109998","article-title":"Prevalence of dementia in the United States: the aging, demographics, and memory study","volume":"29","author":"Plassman","year":"2007","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.neuropharm.2015.02.020_bib39","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-clinpsy-050212-185535","article-title":"Neuroimaging and other biomarkers for Alzheimer's disease: the changing landscape of early detection","volume":"9","author":"Risacher","year":"2013","journal-title":"Annu Rev. Clin. Psychol."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib40","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/BF03401828","article-title":"Bilirubin and amyloid-\u03b2 peptide induce cytochrome c release through mitochondrial membrane permeabilization","volume":"6","author":"Rodrigues","year":"2000","journal-title":"Mol. Med."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib41","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1523\/JNEUROSCI.5242-10.2011","article-title":"Impaired attention in the 3xTgAD mouse model of Alzheimer's disease: rescue by donepezil (Aricept)","volume":"31","author":"Romberg","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib42","doi-asserted-by":"crossref","first-page":"H475","DOI":"10.1152\/ajpheart.00001.2013","article-title":"Epoxyeicosatrienoic acids pretreatment improves amyloid \u03b2-induced mitochondrial dysfunction in cultured rat hippocampal astrocytes","volume":"306","author":"Sarkar","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib43","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0197-4580(86)90055-2","article-title":"Altered structural proteins in plaques and tangles: what do they tell us about the biology of Alzheimer's disease?","volume":"7","author":"Selkoe","year":"1986","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2015.02.020_bib44","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-\u03b2 protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib45","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.neuropharm.2013.06.009","article-title":"Inactivation of muscarinic receptors impairs place and response learning: implications for multiple memory systems","volume":"73","author":"Soares","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.02.020_bib46","doi-asserted-by":"crossref","first-page":"e98866","DOI":"10.1371\/journal.pone.0098866","article-title":"Protective effects of astragaloside IV against A\u03b21-42 neurotoxicity by inhibiting the mitochondrial permeability transition pore opening","volume":"9","author":"Sun","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2015.02.020_bib47","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1096\/fj.04-2582fje","article-title":"ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction","volume":"19","author":"Takuma","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib48","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.neurobiolaging.2013.09.036","article-title":"Involvement of cysteinyl leukotriene receptor 1 in A\u03b21-42-induced neurotoxicity in\u00a0vitro and in\u00a0vivo","volume":"35","author":"Tang","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2015.02.020_bib49","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nprot.2007.44","article-title":"The use of the elevated plus maze as an assay of anxiety-related behavior in rodents","volume":"2","author":"Walf","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib50","doi-asserted-by":"crossref","first-page":"30317","DOI":"10.1074\/jbc.M112.365890","article-title":"Swedish Alzheimer mutation induces mitochondrial dysfunction mediated by HSP60 mislocalization of amyloid precursor protein (APP) and \u03b2-amyloid","volume":"287","author":"Walls","year":"2012","journal-title":"J.\u00a0Bio. Chem."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib51","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/jnr.22237","article-title":"Huperzine A improves chronic inflammation and cognitive decline in rats with cerebral hypoperfusion","volume":"88","author":"Wang","year":"2010","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib52","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.neuropharm.2011.07.013","article-title":"Donepezil reduces cognitive impairment associated with anti-cancer drugs in a mouse model","volume":"61","author":"Winocur","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.02.020_bib53","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3233\/JAD-2012-120274","article-title":"Decreased accumulation of subcellular amyloid-beta with Improved mitochondrial function mediates the neuroprotective effect of Huperzine A","volume":"31","author":"Yang","year":"2012","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2015.02.020_bib54","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1523\/JNEUROSCI.4717-10.2011","article-title":"Inhibition of amyloid-\u03b2 (A\u03b2) peptide-binding alcohol dehydrogenase-Abeta interaction reduces A\u03b2 accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease","volume":"31","author":"Yao","year":"2011","journal-title":"J.\u00a0Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815000672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815000672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T15:25:58Z","timestamp":1717773958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390815000672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":54,"alternative-id":["S0028390815000672"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.02.020","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Donepezil attenuates A\u03b2-associated mitochondrial dysfunction and\u00a0reduces mitochondrial A\u03b2 accumulation in\u00a0vivo and in\u00a0vitro","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}